Determination of 17q gain in patients with neuroblastoma by analysis of circulating DNA-Reference-Cited by-同舟云学术

Determination of 17q gain in patients with neuroblastoma by analysis of circulating DNA

Published:2011-01-11 Issue:5 Volume:56 Page:757-761
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Combaret Valérie,Bréjon Stéphanie,Iacono Isabelle,Schleiermacher Gudrun,Pierron Gäelle,Ribeiro Agnès,Bergeron Christophe,Marabelle Aurélien,Puisieux Alain

Funder

Comité Départemental de la Saône et Loire, Comité Départemental de l'Ain of the French Ligue Nationale de Lutte Contre le Cancer

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.22816/fullpdf

Reference30 articles.

1. Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplification;Schleiermacher;Br J Cancer,2007

2. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression;Mosse;Genes Chromosomes Cancer,2007

3. Novel risk stratification of patients with neuroblastoma by genomic signature, which is independent of molecular signature;Tomioka;Oncogene,2008

4. Overall genomic pattern is a predictor of outcome in neuroblastoma;Janoueix-Lerosey;J Clin Oncol,2009

5. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset;Carén;Proc Natl Acad Sci USA,2010

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive overview of liquid biopsy applications in pediatric solid tumors;npj Precision Oncology;2024-08-03

2. 17q Gain in Neuroblastoma: A Review of Clinical and Biological Implications;Cancers;2024-01-12

3. Narrative review: precision medicine applications in neuroblastoma—current status and future prospects;Translational Pediatrics;2024-01

4. Somatic Genomic Alterations in Neuroblastoma;Pediatric Oncology;2024

5. Targeted parallel DNA sequencing detects circulating tumor‐associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma;Cancer Reports;2022-07-28